Share Price and Basic Stock Data
Last Updated: December 19, 2025, 4:48 am
| PEG Ratio | -3.60 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Emkay Global Financial Services Ltd operates in the finance and investments sector, showcasing a diverse range of services. The company’s revenue trajectory has shown significant volatility over the past few quarters. For instance, sales dipped to ₹42.15 Cr in March 2023 but rebounded impressively to ₹70.54 Cr by September 2023, and further to ₹75.20 Cr in December 2023. This recovery is notable, especially after a challenging fiscal year where total sales for FY 2023 stood at ₹215 Cr, down from ₹272 Cr in FY 2022. The company’s TTM sales currently reflect a promising ₹329 Cr, suggesting a positive trend moving forward. However, fluctuations in revenue can indicate underlying challenges in maintaining consistent client engagement or market conditions, both of which are crucial for a financial services firm.
Profitability and Efficiency Metrics
The profitability metrics of Emkay Global depict a mixed performance, particularly in operational efficiency. The operating profit margin (OPM) fell sharply to -28.09% in March 2023, reflecting significant challenges during that period. However, the OPM has shown signs of recovery, standing at 7.99% in the latest reporting period. The return on equity (ROE) is a robust 20.9%, indicating that the company is effectively utilizing shareholders’ funds to generate profits. Yet, it is important to note that the interest coverage ratio (ICR) is at a comfortable 11.40x, suggesting that Emkay can comfortably meet its interest obligations. Despite these strengths, the company’s net profit margin, which has fluctuated, stood at 16.93% in March 2025, highlighting the need for a more stable profitability framework.
Balance Sheet Strength and Financial Ratios
Emkay Global’s balance sheet reflects a cautious yet strategic approach to financial management. With total borrowings reported at ₹81 Cr against reserves of ₹276 Cr, the company maintains a manageable debt-to-equity ratio of 0.19. This suggests a low leverage position, which can be advantageous in uncertain market conditions. The book value per share has seen a steady increase, reaching ₹119.51 in March 2025, indicating a solid capital base. Furthermore, the price-to-book value (P/BV) ratio of 1.78x suggests that the stock is trading at a premium compared to its book value, which could imply strong market confidence in its future growth. However, the cash conversion cycle (CCC) stands at 95 days, which, while improved, still indicates potential inefficiencies in managing receivables and payables.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Emkay Global reveals a significant promoter holding of 71.68%, which can be a double-edged sword. On one hand, high promoter ownership often indicates strong management commitment. On the other hand, the declining trend in promoter holdings—from 74.49% in December 2022 to 71.68% in September 2025—might raise concerns among investors regarding insider confidence in the company’s future. Foreign institutional investors (FIIs) hold a mere 0.88%, while domestic institutional investors (DIIs) are almost negligible at 0.03%. This sparse institutional interest could suggest a lack of confidence or awareness among larger investors. However, the public shareholding has increased to 27.41%, which may reflect a growing retail interest in the stock, indicating a potential shift in investor sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Emkay Global is positioned in a sector that often faces headwinds, including regulatory changes and market volatility. While the recent uptick in sales and profitability metrics provides a glimmer of hope, the company must address its operational inefficiencies and ensure consistent revenue generation to sustain investor confidence. Risks such as high promoter stake dilution, fluctuating profitability, and a low institutional investor base could pose challenges. Investors should consider these factors carefully, weighing the company’s potential for recovery against its inherent risks. The evolving landscape of financial services in India, coupled with Emkay’s strategic positioning, might present opportunities for growth, but a cautious approach is warranted. Overall, the company appears to have a solid foundation, yet it must navigate through its challenges effectively to realize its full potential.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.9 Cr. | 40.5 | 67.7/36.4 | 47.5 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,381 Cr. | 300 | 484/280 | 15.3 | 111 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 33.0 Cr. | 0.47 | 2.02/0.45 | 4.58 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 5.45 Cr. | 11.0 | 12.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 20.8 Cr. | 40.6 | 72.0/40.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,228.45 Cr | 1,373.88 | 82.41 | 3,844.37 | 0.36% | 21.71% | 14.20% | 7.22 |
All Competitor Stocks of Emkay Global Financial Services Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 51.97 | 56.62 | 54.32 | 42.15 | 46.65 | 70.54 | 75.20 | 90.98 | 82.69 | 108.02 | 77.30 | 71.04 | 72.97 |
| Expenses | 43.22 | 46.98 | 47.91 | 53.99 | 52.21 | 62.98 | 64.70 | 78.10 | 67.61 | 78.93 | 67.87 | 70.93 | 67.14 |
| Operating Profit | 8.75 | 9.64 | 6.41 | -11.84 | -5.56 | 7.56 | 10.50 | 12.88 | 15.08 | 29.09 | 9.43 | 0.11 | 5.83 |
| OPM % | 16.84% | 17.03% | 11.80% | -28.09% | -11.92% | 10.72% | 13.96% | 14.16% | 18.24% | 26.93% | 12.20% | 0.15% | 7.99% |
| Other Income | 1.41 | 1.34 | 1.94 | 8.30 | 9.13 | 7.52 | 8.19 | 8.44 | 6.43 | 6.78 | 6.58 | 5.81 | 4.78 |
| Interest | 0.78 | 0.91 | 1.25 | 1.34 | 0.83 | 1.12 | 1.29 | 1.66 | 1.78 | 1.65 | 1.84 | 1.68 | 2.44 |
| Depreciation | 2.02 | 2.28 | 2.44 | 2.44 | 1.98 | 2.08 | 2.68 | 3.06 | 2.62 | 2.79 | 2.94 | 3.29 | 2.91 |
| Profit before tax | 7.36 | 7.79 | 4.66 | -7.32 | 0.76 | 11.88 | 14.72 | 16.60 | 17.11 | 31.43 | 11.23 | 0.95 | 5.26 |
| Tax % | 40.35% | 19.64% | -84.55% | -27.46% | 119.74% | 18.94% | 16.51% | 37.35% | 18.47% | 17.88% | 22.26% | -786.32% | 8.75% |
| Net Profit | 4.58 | 6.12 | 8.74 | -5.37 | 0.34 | 9.27 | 12.26 | 10.56 | 13.87 | 25.91 | 8.57 | 8.49 | 4.78 |
| EPS in Rs | 1.86 | 2.48 | 3.55 | -2.18 | 0.14 | 3.76 | 4.97 | 4.28 | 5.61 | 10.43 | 3.43 | 3.35 | 1.88 |
Last Updated: August 20, 2025, 11:10 am
Below is a detailed analysis of the quarterly data for Emkay Global Financial Services Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 72.97 Cr.. The value appears strong and on an upward trend. It has increased from 71.04 Cr. (Mar 2025) to 72.97 Cr., marking an increase of 1.93 Cr..
- For Expenses, as of Jun 2025, the value is 67.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 70.93 Cr. (Mar 2025) to 67.14 Cr., marking a decrease of 3.79 Cr..
- For Operating Profit, as of Jun 2025, the value is 5.83 Cr.. The value appears strong and on an upward trend. It has increased from 0.11 Cr. (Mar 2025) to 5.83 Cr., marking an increase of 5.72 Cr..
- For OPM %, as of Jun 2025, the value is 7.99%. The value appears strong and on an upward trend. It has increased from 0.15% (Mar 2025) to 7.99%, marking an increase of 7.84%.
- For Other Income, as of Jun 2025, the value is 4.78 Cr.. The value appears to be declining and may need further review. It has decreased from 5.81 Cr. (Mar 2025) to 4.78 Cr., marking a decrease of 1.03 Cr..
- For Interest, as of Jun 2025, the value is 2.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.68 Cr. (Mar 2025) to 2.44 Cr., marking an increase of 0.76 Cr..
- For Depreciation, as of Jun 2025, the value is 2.91 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.29 Cr. (Mar 2025) to 2.91 Cr., marking a decrease of 0.38 Cr..
- For Profit before tax, as of Jun 2025, the value is 5.26 Cr.. The value appears strong and on an upward trend. It has increased from 0.95 Cr. (Mar 2025) to 5.26 Cr., marking an increase of 4.31 Cr..
- For Tax %, as of Jun 2025, the value is 8.75%. The value appears to be increasing, which may not be favorable. It has increased from -786.32% (Mar 2025) to 8.75%, marking an increase of 795.07%.
- For Net Profit, as of Jun 2025, the value is 4.78 Cr.. The value appears to be declining and may need further review. It has decreased from 8.49 Cr. (Mar 2025) to 4.78 Cr., marking a decrease of 3.71 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.88. The value appears to be declining and may need further review. It has decreased from 3.35 (Mar 2025) to 1.88, marking a decrease of 1.47.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:24 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82 | 117 | 105 | 109 | 156 | 147 | 135 | 160 | 272 | 215 | 314 | 360 | 293 |
| Expenses | 76 | 82 | 82 | 85 | 111 | 124 | 137 | 134 | 217 | 189 | 258 | 282 | 277 |
| Operating Profit | 6 | 34 | 24 | 24 | 45 | 23 | -3 | 26 | 55 | 25 | 56 | 79 | 17 |
| OPM % | 8% | 29% | 22% | 22% | 29% | 15% | -2% | 16% | 20% | 12% | 18% | 22% | 6% |
| Other Income | 1 | -36 | 0 | 0 | 0 | 3 | 0 | 2 | 1 | 1 | 2 | 1 | 22 |
| Interest | 5 | 5 | 4 | 3 | 4 | 7 | 7 | 3 | 3 | 4 | 5 | 7 | 9 |
| Depreciation | 4 | 4 | 4 | 4 | 5 | 7 | 8 | 8 | 8 | 9 | 10 | 12 | 12 |
| Profit before tax | -3 | -11 | 17 | 16 | 37 | 12 | -17 | 17 | 46 | 12 | 44 | 61 | 18 |
| Tax % | 40% | 49% | 28% | 26% | 22% | 31% | -29% | 32% | 24% | -12% | 27% | 6% | |
| Net Profit | -4 | -16 | 12 | 12 | 29 | 9 | -13 | 11 | 34 | 14 | 32 | 57 | 22 |
| EPS in Rs | -1.62 | -6.44 | 4.92 | 4.99 | 11.66 | 3.55 | -5.11 | 4.52 | 13.72 | 5.71 | 13.14 | 22.40 | 8.84 |
| Dividend Payout % | 0% | 0% | 20% | 20% | 17% | 28% | 0% | 22% | 9% | 18% | 11% | 18% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -300.00% | 175.00% | 0.00% | 141.67% | -68.97% | -244.44% | 184.62% | 209.09% | -58.82% | 128.57% | 78.12% |
| Change in YoY Net Profit Growth (%) | 0.00% | 475.00% | -175.00% | 141.67% | -210.63% | -175.48% | 429.06% | 24.48% | -267.91% | 187.39% | -50.45% |
Emkay Global Financial Services Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 22% |
| 3 Years: | 10% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 46% |
| 3 Years: | 19% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 31% |
| 3 Years: | 36% |
| 1 Year: | 19% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 21% |
Last Updated: September 5, 2025, 3:30 am
Balance Sheet
Last Updated: December 4, 2025, 1:12 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 26 |
| Reserves | 105 | 89 | 98 | 111 | 137 | 142 | 128 | 142 | 176 | 186 | 216 | 278 | 276 |
| Borrowings | 34 | 35 | 11 | 49 | 34 | 23 | 10 | 17 | 44 | 33 | 52 | 68 | 81 |
| Other Liabilities | 110 | 112 | 92 | 116 | 169 | 136 | 218 | 381 | 519 | 488 | 772 | 862 | 1,159 |
| Total Liabilities | 274 | 261 | 226 | 299 | 365 | 326 | 381 | 565 | 764 | 731 | 1,065 | 1,233 | 1,542 |
| Fixed Assets | 39 | 36 | 35 | 35 | 33 | 35 | 38 | 34 | 32 | 38 | 43 | 41 | 43 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
| Investments | 3 | 4 | 11 | 26 | 36 | 28 | 16 | 29 | 34 | 24 | 26 | 32 | 40 |
| Other Assets | 232 | 221 | 180 | 237 | 296 | 263 | 327 | 501 | 696 | 669 | 996 | 1,160 | 1,459 |
| Total Assets | 274 | 261 | 226 | 299 | 365 | 326 | 381 | 565 | 764 | 731 | 1,065 | 1,233 | 1,542 |
Below is a detailed analysis of the balance sheet data for Emkay Global Financial Services Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Sep 2025, the value is 276.00 Cr.. The value appears to be declining and may need further review. It has decreased from 278.00 Cr. (Mar 2025) to 276.00 Cr., marking a decrease of 2.00 Cr..
- For Borrowings, as of Sep 2025, the value is 81.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 68.00 Cr. (Mar 2025) to 81.00 Cr., marking an increase of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,159.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 862.00 Cr. (Mar 2025) to 1,159.00 Cr., marking an increase of 297.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,542.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,233.00 Cr. (Mar 2025) to 1,542.00 Cr., marking an increase of 309.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 43.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Mar 2025) to 43.00 Cr., marking an increase of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 8.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,459.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,160.00 Cr. (Mar 2025) to 1,459.00 Cr., marking an increase of 299.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,542.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,233.00 Cr. (Mar 2025) to 1,542.00 Cr., marking an increase of 309.00 Cr..
Notably, the Reserves (276.00 Cr.) exceed the Borrowings (81.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -28.00 | -1.00 | 13.00 | -25.00 | 11.00 | 0.00 | -13.00 | 9.00 | 11.00 | -8.00 | 4.00 | 11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 173 | 169 | 66 | 218 | 208 | 146 | 145 | 152 | 119 | 179 | 145 | 95 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 173 | 169 | 66 | 218 | 208 | 146 | 145 | 152 | 119 | 179 | 145 | 95 |
| Working Capital Days | -6 | -59 | -161 | -172 | -150 | -134 | -353 | -564 | -372 | -380 | -463 | -271 |
| ROCE % | 2% | 19% | 14% | 12% | 22% | 9% | -6% | 12% | 23% | 7% | 17% | 20% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 22.80 | 13.16 | 5.71 | 13.72 | 4.52 |
| Diluted EPS (Rs.) | 21.95 | 12.74 | 5.68 | 12.97 | 4.52 |
| Cash EPS (Rs.) | 27.02 | 17.00 | 9.39 | 17.22 | 7.90 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 119.51 | 97.54 | 85.38 | 81.42 | 67.59 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 119.51 | 97.54 | 85.38 | 81.42 | 67.59 |
| Revenue From Operations / Share (Rs.) | 132.52 | 114.39 | 82.39 | 110.07 | 66.00 |
| PBDIT / Share (Rs.) | 31.27 | 23.13 | 10.55 | 23.07 | 12.30 |
| PBIT / Share (Rs.) | 26.68 | 19.16 | 6.83 | 20.00 | 9.20 |
| PBT / Share (Rs.) | 23.94 | 17.18 | 5.09 | 18.72 | 7.05 |
| Net Profit / Share (Rs.) | 22.44 | 13.03 | 5.66 | 14.15 | 4.80 |
| NP After MI And SOA / Share (Rs.) | 22.40 | 13.14 | 5.71 | 13.72 | 4.52 |
| PBDIT Margin (%) | 23.59 | 20.22 | 12.81 | 20.96 | 18.63 |
| PBIT Margin (%) | 20.13 | 16.75 | 8.28 | 18.16 | 13.94 |
| PBT Margin (%) | 18.06 | 15.01 | 6.17 | 17.00 | 10.68 |
| Net Profit Margin (%) | 16.93 | 11.39 | 6.87 | 12.85 | 7.28 |
| NP After MI And SOA Margin (%) | 16.90 | 11.48 | 6.93 | 12.46 | 6.85 |
| Return on Networth / Equity (%) | 18.74 | 13.46 | 6.69 | 16.84 | 6.69 |
| Return on Capital Employeed (%) | 16.67 | 15.98 | 6.82 | 18.20 | 11.91 |
| Return On Assets (%) | 4.60 | 3.04 | 1.92 | 4.42 | 1.97 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.14 | 0.01 |
| Total Debt / Equity (X) | 0.19 | 0.17 | 0.12 | 0.19 | 0.07 |
| Asset Turnover Ratio (%) | 0.29 | 0.31 | 0.26 | 0.27 | 0.31 |
| Current Ratio (X) | 1.41 | 1.31 | 1.38 | 1.46 | 1.38 |
| Quick Ratio (X) | 1.41 | 1.31 | 1.38 | 1.46 | 1.38 |
| Dividend Payout Ratio (NP) (%) | 6.54 | 7.59 | 21.88 | 7.28 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 5.43 | 5.83 | 13.24 | 5.94 | 0.00 |
| Earning Retention Ratio (%) | 93.46 | 92.41 | 78.12 | 92.72 | 0.00 |
| Cash Earning Retention Ratio (%) | 94.57 | 94.17 | 86.76 | 94.06 | 0.00 |
| Interest Coverage Ratio (X) | 11.40 | 11.64 | 6.08 | 18.01 | 5.73 |
| Interest Coverage Ratio (Post Tax) (X) | 9.18 | 7.24 | 4.27 | 12.06 | 3.24 |
| Enterprise Value (Cr.) | 58.78 | -251.00 | -164.08 | -116.33 | -163.84 |
| EV / Net Operating Revenue (X) | 0.17 | -0.88 | -0.80 | -0.42 | -1.01 |
| EV / EBITDA (X) | 0.74 | -4.39 | -6.31 | -2.05 | -5.41 |
| MarketCap / Net Operating Revenue (X) | 1.60 | 1.02 | 0.78 | 0.94 | 0.98 |
| Retention Ratios (%) | 93.45 | 92.40 | 78.11 | 92.71 | 0.00 |
| Price / BV (X) | 1.78 | 1.20 | 0.75 | 1.28 | 0.96 |
| Price / Net Operating Revenue (X) | 1.60 | 1.02 | 0.78 | 0.94 | 0.98 |
| EarningsYield | 0.10 | 0.11 | 0.08 | 0.13 | 0.06 |
After reviewing the key financial ratios for Emkay Global Financial Services Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 22.80. This value is within the healthy range. It has increased from 13.16 (Mar 24) to 22.80, marking an increase of 9.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 21.95. This value is within the healthy range. It has increased from 12.74 (Mar 24) to 21.95, marking an increase of 9.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 27.02. This value is within the healthy range. It has increased from 17.00 (Mar 24) to 27.02, marking an increase of 10.02.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.51. It has increased from 97.54 (Mar 24) to 119.51, marking an increase of 21.97.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.51. It has increased from 97.54 (Mar 24) to 119.51, marking an increase of 21.97.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 132.52. It has increased from 114.39 (Mar 24) to 132.52, marking an increase of 18.13.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 31.27. This value is within the healthy range. It has increased from 23.13 (Mar 24) to 31.27, marking an increase of 8.14.
- For PBIT / Share (Rs.), as of Mar 25, the value is 26.68. This value is within the healthy range. It has increased from 19.16 (Mar 24) to 26.68, marking an increase of 7.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 23.94. This value is within the healthy range. It has increased from 17.18 (Mar 24) to 23.94, marking an increase of 6.76.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 22.44. This value is within the healthy range. It has increased from 13.03 (Mar 24) to 22.44, marking an increase of 9.41.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 22.40. This value is within the healthy range. It has increased from 13.14 (Mar 24) to 22.40, marking an increase of 9.26.
- For PBDIT Margin (%), as of Mar 25, the value is 23.59. This value is within the healthy range. It has increased from 20.22 (Mar 24) to 23.59, marking an increase of 3.37.
- For PBIT Margin (%), as of Mar 25, the value is 20.13. This value exceeds the healthy maximum of 20. It has increased from 16.75 (Mar 24) to 20.13, marking an increase of 3.38.
- For PBT Margin (%), as of Mar 25, the value is 18.06. This value is within the healthy range. It has increased from 15.01 (Mar 24) to 18.06, marking an increase of 3.05.
- For Net Profit Margin (%), as of Mar 25, the value is 16.93. This value exceeds the healthy maximum of 10. It has increased from 11.39 (Mar 24) to 16.93, marking an increase of 5.54.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.90. This value is within the healthy range. It has increased from 11.48 (Mar 24) to 16.90, marking an increase of 5.42.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.74. This value is within the healthy range. It has increased from 13.46 (Mar 24) to 18.74, marking an increase of 5.28.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.67. This value is within the healthy range. It has increased from 15.98 (Mar 24) to 16.67, marking an increase of 0.69.
- For Return On Assets (%), as of Mar 25, the value is 4.60. This value is below the healthy minimum of 5. It has increased from 3.04 (Mar 24) to 4.60, marking an increase of 1.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.19, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.29. It has decreased from 0.31 (Mar 24) to 0.29, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 1.5. It has increased from 1.31 (Mar 24) to 1.41, marking an increase of 0.10.
- For Quick Ratio (X), as of Mar 25, the value is 1.41. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 1.41, marking an increase of 0.10.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.54. This value is below the healthy minimum of 20. It has decreased from 7.59 (Mar 24) to 6.54, marking a decrease of 1.05.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.43. This value is below the healthy minimum of 20. It has decreased from 5.83 (Mar 24) to 5.43, marking a decrease of 0.40.
- For Earning Retention Ratio (%), as of Mar 25, the value is 93.46. This value exceeds the healthy maximum of 70. It has increased from 92.41 (Mar 24) to 93.46, marking an increase of 1.05.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.57. This value exceeds the healthy maximum of 70. It has increased from 94.17 (Mar 24) to 94.57, marking an increase of 0.40.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 11.40. This value is within the healthy range. It has decreased from 11.64 (Mar 24) to 11.40, marking a decrease of 0.24.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.18. This value is within the healthy range. It has increased from 7.24 (Mar 24) to 9.18, marking an increase of 1.94.
- For Enterprise Value (Cr.), as of Mar 25, the value is 58.78. It has increased from -251.00 (Mar 24) to 58.78, marking an increase of 309.78.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 1. It has increased from -0.88 (Mar 24) to 0.17, marking an increase of 1.05.
- For EV / EBITDA (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 5. It has increased from -4.39 (Mar 24) to 0.74, marking an increase of 5.13.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.02 (Mar 24) to 1.60, marking an increase of 0.58.
- For Retention Ratios (%), as of Mar 25, the value is 93.45. This value exceeds the healthy maximum of 70. It has increased from 92.40 (Mar 24) to 93.45, marking an increase of 1.05.
- For Price / BV (X), as of Mar 25, the value is 1.78. This value is within the healthy range. It has increased from 1.20 (Mar 24) to 1.78, marking an increase of 0.58.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.02 (Mar 24) to 1.60, marking an increase of 0.58.
- For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.10, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Emkay Global Financial Services Ltd:
- Net Profit Margin: 16.93%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.67% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.74% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.18
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.41
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.3 (Industry average Stock P/E: 82.41)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 16.93%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | The Ruby, 7th Floor, Mumbai Maharashtra 400028 | secretarial@emkayglobal.com http://www.emkayglobal.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S K Saboo | Chairman |
| Mr. Krishna Kumar Karwa | Managing Director |
| Mr. Prakash Kacholia | Managing Director |
| Mr. Raunak Karwa | Non Executive Director |
| Dr. Bharat Kumar Singh | Independent Director |
| Dr. Satish Ugrankar | Independent Director |
| Mr. A Dhananjaya | Independent Director |
| Mrs. Hutokshi Wadia | Independent Woman Director |
FAQ
What is the intrinsic value of Emkay Global Financial Services Ltd?
Emkay Global Financial Services Ltd's intrinsic value (as of 19 December 2025) is 601.27 which is 130.37% higher the current market price of 261.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 676 Cr. market cap, FY2025-2026 high/low of 410/162, reserves of ₹276 Cr, and liabilities of 1,542 Cr.
What is the Market Cap of Emkay Global Financial Services Ltd?
The Market Cap of Emkay Global Financial Services Ltd is 676 Cr..
What is the current Stock Price of Emkay Global Financial Services Ltd as on 19 December 2025?
The current stock price of Emkay Global Financial Services Ltd as on 19 December 2025 is 261.
What is the High / Low of Emkay Global Financial Services Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Emkay Global Financial Services Ltd stocks is 410/162.
What is the Stock P/E of Emkay Global Financial Services Ltd?
The Stock P/E of Emkay Global Financial Services Ltd is 30.3.
What is the Book Value of Emkay Global Financial Services Ltd?
The Book Value of Emkay Global Financial Services Ltd is 118.
What is the Dividend Yield of Emkay Global Financial Services Ltd?
The Dividend Yield of Emkay Global Financial Services Ltd is 0.58 %.
What is the ROCE of Emkay Global Financial Services Ltd?
The ROCE of Emkay Global Financial Services Ltd is 20.4 %.
What is the ROE of Emkay Global Financial Services Ltd?
The ROE of Emkay Global Financial Services Ltd is 20.9 %.
What is the Face Value of Emkay Global Financial Services Ltd?
The Face Value of Emkay Global Financial Services Ltd is 10.0.